| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5mg | ¥ 787.00 | 100 | |
| 10mg | ¥ 1505.00 | 100 | |
| 50mg | ¥ 6750.00 | 100 |
| 别名 | 去水淫羊藿黄素; 脱水淫羊藿素,淫羊藿苷 |
| 产品名 | Icaritin (Anhydroicaritin) |
| CAS号 | 118525-40-9 |
| 目录号 | D932762 |
| 化学式 | C₂₁H₂₀O₆ |
| 分子量 | 368.38 |
| 溶解度 | DMSO : 14 mg/mL (38.00 mM) |
| 靶点 | 脱水淫羊藿素(Icaritin)是一被报道有抗癌活性的天然化合物,可能通过调节MAPK/ERK/JNK和JAK2/STAT3/AKT信号通路。 |
| 储存条件 | Store at -20°C |
| 用途 | 仅供科学研究使用!不能用于人体及动物治疗 |
| 纯度 | >99% |
靶点及简介 :脱水淫羊藿素(Icaritin)是一被报道有抗癌活性的天然化合物,可能通过调节MAPK/ERK/JNK和JAK2/STAT3/AKT信号通路。
Icaritin (Anhydroicaritin) potently inhibits proliferation of K562 cells (IC50 of 8 µM) and primary CML cells (IC50 of 13.4 µM for CML-CP and 18 µM for CML-BC). Icaritin can regulate MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings, also enhances osteogenesis.
Icaritin is an oral traditional Chinese medicine, derived from barrenwort, which targets the estrogen receptor α36. IC50 values for Icaritin are 8,13 and 18 μM for K562, CML-CP and CML-BC cells respectively. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling. Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells.
参考文献:
| Max Conc. mg/mL | Max Conc. mM |
Solubility | ||
DMF | 3.0 | 8.14 |
DMSO | 10.31 | 27.99 |
DMSO:PBS (pH 7.2) (1:5) | 0.16 | 0.43 |
Ethanol | 0.3 | 0.81 |
Water | 1.2 | 3.26 |
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.71 mL | 13.57 mL | 27.15 mL |
| 5 mM | 0.54 mL | 2.71 mL | 5.43 mL |
| 10 mM | 0.27 mL | 1.36 mL | 2.71 mL |
| 50 mM | 0.05 mL | 0.27 mL | 0.54 mL |